These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10815930)

  • 41. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.
    Dallas NA; Samuel S; Xia L; Fan F; Gray MJ; Lim SJ; Ellis LM
    Clin Cancer Res; 2008 Apr; 14(7):1931-7. PubMed ID: 18381930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.
    Li C; Guo B; Bernabeu C; Kumar S
    Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).
    Völkel T; Hölig P; Merdan T; Müller R; Kontermann RE
    Biochim Biophys Acta; 2004 May; 1663(1-2):158-66. PubMed ID: 15157618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice.
    Karmani L; Levêque P; Bouzin C; Bol A; Dieu M; Walrand S; Vander Borght T; Feron O; Grégoire V; Bonifazi D; Michiels C; Lucas S; Gallez B
    Nucl Med Biol; 2016 Jul; 43(7):415-23. PubMed ID: 27179250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.
    Charpin C; Dales JP; Garcia S; Carpentier S; Djemli A; Andrac L; Lavaut MN; Allasia C; Bonnier P
    Clin Cancer Res; 2004 Sep; 10(17):5815-9. PubMed ID: 15355911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).
    Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Taranger-Charpin C
    Br J Cancer; 2004 Mar; 90(6):1216-21. PubMed ID: 15026804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors.
    Vanzulli S; Gazzaniga S; Braidot MF; Vecchi A; Mantovani A; Wainstok de Calmanovici R
    Biocell; 1997 Apr; 21(1):39-46. PubMed ID: 9212717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells.
    Miller DW; Graulich W; Karges B; Stahl S; Ernst M; Ramaswamy A; Sedlacek HH; Müller R; Adamkiewicz J
    Int J Cancer; 1999 May; 81(4):568-72. PubMed ID: 10225446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
    Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
    Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105).
    Toi H; Tsujie M; Haruta Y; Fujita K; Duzen J; Seon BK
    Int J Cancer; 2015 Jan; 136(2):452-61. PubMed ID: 24866768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells.
    Li C; Hampson IN; Hampson L; Kumar P; Bernabeu C; Kumar S
    FASEB J; 2000 Jan; 14(1):55-64. PubMed ID: 10627280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spontaneous canine mammary tumors. A model for monoclonal antibody diagnosis and treatment of human breast cancer.
    Mottolese M; Morelli L; Agrimi U; Benevolo M; Sciarretta F; Antonucci G; Natali PG
    Lab Invest; 1994 Aug; 71(2):182-7. PubMed ID: 8078297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial cell and stromal antigens in human periapical granulation tissue.
    Taşman F; Dağdeviren A; Kendir B; Er N; Ataç A
    J Endod; 2000 Feb; 26(2):81-4. PubMed ID: 11194377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation molecule.
    O'Connell PJ; McKenzie A; Fisicaro N; Rockman SP; Pearse MJ; d'Apice AJ
    Clin Exp Immunol; 1992 Oct; 90(1):154-9. PubMed ID: 1395096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor neoangiogenesis detection by confocal laser endomicroscopy and anti-CD105 antibody: Pilot study.
    Ciocâlteu A; Săftoiu A; Pirici D; Georgescu CV; Cârţână T; Gheonea DI; Gruionu LG; Cristea CG; Gruionu G
    World J Gastrointest Oncol; 2015 Nov; 7(11):361-8. PubMed ID: 26600936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. (89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.
    Karmani L; Bouchat V; Bouzin C; Levêque P; Labar D; Bol A; Deumer G; Marega R; Bonifazi D; Haufroid V; Michiels C; Grégoire V; Feron O; Lucas S; Vander Borght T; Gallez B
    Nanomedicine (Lond); 2014 Sep; 9(13):1923-37. PubMed ID: 24547782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunodetection and characterisation of soluble CD105-TGFbeta complexes.
    Li CG; Wilson PB; Bernabeu C; Raab U; Wang JM; Kumar S
    J Immunol Methods; 1998 Sep; 218(1-2):85-93. PubMed ID: 9819125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.